Home/Filings/4/0000950170-24-019463
4//SEC Filing

Savill Corrine 4

Accession 0000950170-24-019463

CIK 0001789972other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 5:00 PM ET

Size

7.1 KB

Accession

0000950170-24-019463

Insider Transaction Report

Form 4
Period: 2024-02-22
Savill Corrine
Chief Business Officer
Transactions
  • Award

    Common Stock

    2024-02-22+37,500203,490 total
  • Award

    Stock Option (Right to Buy)

    2024-02-22+75,00075,000 total
    Exercise: $17.54Exp: 2034-02-22Common Stock (75,000 underlying)
Footnotes (2)
  • [F1]The shares underlying the restricted stock unit vest on an annual basis over four years.
  • [F2]The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.

Documents

1 file

Issuer

Cullinan Oncology, Inc.

CIK 0001789972

Entity typeother

Related Parties

1
  • filerCIK 0001837524

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 5:00 PM ET
Size
7.1 KB